PR Newswire Asia's news > Health Care/Hospital

 < Previous page   |   Title only   |   Print    Next page > 
     
Priority Review Granted to PD-L1/4-1BB Bispecific Antibody Opamtistomig, Accelerating Commercialization and Addressing Unmet Need in EP-NEC
NANJING, China , July 10, 2026 /PRNewswire/ -- Nanjing Leads Biolabs Co., Ltd. ("Leads Biolabs" or the "Company," Stock Code: 9887.HK) today announced that the biologics license ...
2026-07-10T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Insilico Medicine Releases Positive Profit Alert for the First Half of 2026
CAMBRIDGE, Mass. , July 9, 2026 /PRNewswire/ -- Insilico Medicine ("Insilico" or the "Company", HKEX: 3696), a generative artificial intelligence (AI)-driven clinical-stage biotech ...
2026-07-09T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Lynk Pharmaceuticals Announces First Patient Dosed in Phase II Clinical Trial of LNK01004 Ointment for Vitiligo
HANGZHOU, China, SHANGHAI and BOSTON , July 9, 2026 /PRNewswire/ -- Lynk Pharmaceuticals Co., Ltd. ("Lynk Pharmaceuticals"), a clinical-stage innovative drug development company focused on ...
2026-07-09T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
On the Eve of BIO 2026, Chinese Innovative Assets Trigger a New Wave of Global Collaborations
SAN DIEGO, July 9, 2026 /PRNewswire/ -- On the eve of the highly anticipated BIO International Convention 2026, the BIOSeedin Summer Innovation Partnering Summit successfully took place in San Diego. ...
2026-07-09T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Tsingke Highlights AI-Driven CLDN18.2 Antibody Discovery at AIS 2026
MONTPELLIER, France , July 8, 2026 /PRNewswire/ -- Tsingke, a provider of integrated life science research solutions, participated in the Antibody Industrial Symposium (AIS) 2026, one of Europe's leading ...
2026-07-08T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Vermon launches Vermon Group, accelerating its growth and expanding its offerings
Vermon Group opens a new chapter with the acquisition of Moduleus, the opening of TransducerWorks' new U.S. manufacturing facility, and the launch of a coordinated Group platform designed to move faster, ...
2026-07-08T    Computer/Electronics   Health Care/Hospital   Medical Equipment 
Altruist Biologics' Hangzhou Antibody-Drug Conjugate Facility Receives Provincial Regulatory Approval for Segmented Production
First antibody-drug conjugate facility to receive three provincial regulatory approvals for segmented manufacturing. Demonstrated a unified quality system, strict risk assessment protocols, and compliance ...
2026-07-08T    Health Care/Hospital   Medical/Pharmaceuticals 
Global Care Economy Set to Create Significant Growth Opportunities as Care-Dependent Population Reaches up to 4.6 Billion by 2035
Rapid population ageing and care worker shortages are accelerating demand for next-generation care infrastructure, AgeTech, and integrated care ecosystems ...
2026-07-08T    Computer Software   Computer/Electronics   Health Care/Hospital 
Seegene Launches Industry's First Global Million Clinical Study to Shape New Disease-Specific Testing Standards
Seegene is launching the Global Million Clinical Study at the scale of one million test cases to shape disease-specific testing standards. The study is designed to evaluate the clinical utility of syndromic ...
2026-07-08T    Health Care/Hospital   Medical/Pharmaceuticals 
BB Energy Secures Three Additional South Sudan Crude Oil Cargoes
LONDON , July 8, 2026 /PRNewswire/ -- BB Energy secures three additional crude oil cargos from the Republic of South Sudan. ...
2026-07-08T    Banking/Financial Service   Health Care/Hospital   Oil/Energy 
 < Previous page    Next page >

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2026 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.